Brain Neoplasms: Clinical Trials

77 trials for Brain Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

30 completed, 14 recruiting, 13 terminated, 6 active not recruiting. 77 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 177Completed 30, Recruiting 14, Terminated 13, Active not recruiting 6, Not yet recruiting 6, Withdrawn 4, Unknown 3, Enrolling by invitation 1

Follow Brain Neoplasms: new trials by email Literature Review of Brain Neoplasms trials Research Report on Brain Neoplasms

Trials (filtered) newest first · largest first

All 77 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Asciminib With or Without Sildenafil for Brain Tumors
Asciminib, Sildenafil, Surgical resection or biopsy - Brain Tumor
Early Phase 1Not yet recruitingWashington University School of Medicine122026-10-312026-09-11
Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
Panitumumab-IRDye800 - Meningioma, Glioblastoma
Early Phase 1RecruitingEben Rosenthal302026-07-072026-10-16
AI in Endoscopic Transsphenoidal Surgery
Live intra-op AI analysis of endoscopic video feed, with output displayed on supplementary monitor - Pituitary Adenoma
Early Phase 1Not yet recruitingUniversity College, London302026-06-012026-05-05
QH101 Cell Injection in Patients With Brain, Brain (Spinal) Meninges, and Spinal Cord Metastatic Malignant Solid Tumors
QH101 Cell Injection - Brain Metastasis, Meningeal Metastasis
Early Phase 1Not yet recruitingCancer Institute and Hospital, Chinese Academy of Medical Sciences72026-05-312026-06-18
FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease
Fluoro-O-(2) fluoroethyl-L-tyrosine (FET) PET - Cushing Disease, Pituitary Adenoma
Early Phase 1RecruitingMayo Clinic502026-04-272026-10-30
Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)
Nivolumab, Nivolumab-IRDye800 - Brain Cancer, HGG
Early Phase 1RecruitingEben Rosenthal382026-03-272026-07-01
A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies.
SGT-53, hypofractionated radiotherapy with immunotherapy, Nivolumab - CNS Malignancies, Medulloblastoma Recurrent
Early Phase 1RecruitingChildren's National Research Institute182025-12-162026-04-29
Contrast Enhanced Ultrasound in Neurosurgery to Improve Glioma Visualization and Border Demarcation
Definity contrast during ultrasound - Glioma (Any Grade) in the Brain, Glioma
Early Phase 1TerminatedUniversity of Colorado, Denver22025-12-052026-06-22
Clinical Evaluation of [68Ga]Ga-NOTA-RF PET Imaging Targeting RFVT3 in Patients With Pituitary Tumors
[68Ga]Ga-NOTA-RF - Pituitary Neoplasms
Early Phase 1Enrolling by invitationPeking Union Medical College Hospital302025-11-172025-11-28
Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
Cytarabine IT, hydrocortisone, Cisplatin - CNS Embryonal Tumor, CNS, Medulloblastoma
Early Phase 1RecruitingC17 Council152025-09-232026-11-02
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Lorlatinib, Lorlatinib with chemotherapy1, Lorlatinib with chemotherapy 2 - High Grade Glioma, Diffuse Intrinsic Pontine Glioma
Early Phase 1RecruitingNationwide Children's Hospital152025-08-032026-06-29
Window of Opportunity Study of DSP-0390 in Gliomas
DSP-0390 - Glioma, Malignant, IDH Mutation
Early Phase 1RecruitingWashington University School of Medicine202025-04-032026-05-06
Pain Control and Quality of Recovery After Intravenous Methadone Versus Intravenous Remifentanil in Craniotomy Surgery
Remifentanil, Methadone - Brain Injury, Brain Tumors
Early Phase 1RecruitingUniversity of Virginia402025-03-102026-05-04
Lipid Mediators & Cancer: Montelukast, SPM, and Almonds
No Interventions, Sports Pro Resolve 4 g, Double Wood SPM 4 g - Colorectal Cancer, Sarcoma
Early Phase 1Not yet recruitingUniversity of South Florida562025-03-012025-03-20
A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma
Troriluzole - Glioblastoma, Recurrent Glioblastoma
Early Phase 1RecruitingUgonma Chukwueke272025-02-192025-09-11
Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis
18F-Fluciclovine (Axumin) PET/CT - Brain Metastases
Early Phase 1RecruitingUniversity of Arizona202024-09-102026-09-21
Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain Metastases
Arginine, Biospecimen Collection, Computed Tomography - Metastatic Malignant Neoplasm in the Brain, Metastatic Malignant Solid Neoplasm
Early Phase 1RecruitingEmory University102024-09-052026-10-13
Azoles Targeting Recurrent High Grade Gliomas
Ketoconazole (KCZ), Posaconazole (PCZ) - Brain Tumor, Recurrent, Cancer, Advanced
Early Phase 1Not yet recruitingUniversity Health Network, Toronto302024-06-012024-03-08
Clinical Study of Allogeneic Vγ9Vδ2 T Cells in the Treatment of Brain Malignant Glioma
Vγ9Vδ2 T cell - GBM, DIPG Brain Tumor
Early Phase 1Not yet recruitingBeijing Tiantan Hospital252024-04-302024-05-02
A Study of 68Ga-PSMA-11 PET Scans in People With Brain Tumors
68Ga-PSMA-11 PET Scans - High-grade Glioma, Brain Metastases
Early Phase 1Active not recruitingMemorial Sloan Kettering Cancer Center112024-01-052025-12-03

Showing 20 of 77. Sign in to see all of them.

Narrower conditions

Glioma (21)  ·  Glioblastoma (17)  ·  Diffuse Intrinsic Pontine Glioma (7)  ·  Medulloblastoma (7)  ·  Neoplasm Metastasis (6)  ·  Neoplasms (5)  ·  Pituitary Neoplasms (5)  ·  Astrocytoma (4)  ·  Breast Neoplasms (4)  ·  Ependymoma (4)  ·  Central Nervous System Neoplasms (3)  ·  Lung Neoplasms (3)  ·  Melanoma (3)  ·  Ovarian Neoplasms (3)

Broader conditions

Brain Diseases (77)  ·  Central Nervous System Diseases (77)  ·  Neoplasms by Site (77)  ·  Nervous System Diseases (77)  ·  Nervous System Neoplasms (77)  ·  Central Nervous System Neoplasms (74)  ·  Neoplasms (72)  ·  Neoplasms by Histologic Type (49)  ·  Neoplasms, Glandular and Epithelial (46)  ·  Neoplasms, Nerve Tissue (45)  ·  Neuroectodermal Tumors (45)  ·  Neoplasms, Germ Cell and Embryonal (44)  ·  Neoplasms, Neuroepithelial (43)  ·  Glioma (20)

Interventions

Magnetic Resonance Spectroscopy (6)  ·  Temozolomide (5)  ·  Bevacizumab (4)  ·  Biopsy (3)  ·  Nivolumab (3)  ·  Carboplatin (2)  ·  Cyclophosphamide (2)  ·  Etoposide (2)  ·  Filgrastim (2)  ·  Fluorodeoxyglucose F18 (2)  ·  Gemcitabine (2)  ·  Granulocyte Colony-Stimulating Factor (2)  ·  Irinotecan (2)  ·  Ketoconazole (2)  ·  Methotrexate (2)

Sponsors

Case Comprehensive Cancer Center (5)  ·  M.D. Anderson Cancer Center (3)  ·  Mayo Clinic (3)  ·  The University of Texas Health Science Center, Houston (3)  ·  Cedars-Sinai Medical Center (2)  ·  Eben Rosenthal (2)  ·  Emory University (2)  ·  H. Lee Moffitt Cancer Center and Research Institute (2)  ·  Memorial Sloan Kettering Cancer Center (2)  ·  Milton S. Hershey Medical Center (2)  ·  Nationwide Children's Hospital (2)  ·  Northwestern University (2)  ·  Peking Union Medical College Hospital (2)  ·  St. Joseph's Hospital and Medical Center, Phoenix (2)  ·  University of Colorado, Denver (2)

Countries

United States (62)  ·  China (7)  ·  Canada (4)  ·  Germany (3)  ·  Australia (2)  ·  New Zealand (2)  ·  Switzerland (2)  ·  Brazil (1)  ·  France (1)  ·  Japan (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  United Kingdom (1)

Top investigators

Maryam Fouladi, MD (3)  ·  David Sandberg, MD (2)  ·  Nader Sanai, MD (2)  ·  Susan Chi, MD (2)  ·  Adam Green, MD (1)  ·  Alireza Mansouri (1)  ·  Alireza Mansouri, MD (1)  ·  Annie Huang (1)  ·  Anton Nosov, MD (1)  ·  Ashok Srinivasan, M.D. (1)  ·  Bital Savir-Baruch, MD (1)  ·  Boris C Pasche, MD, PhD (1)  ·  Carl Koschmann, M.D. (1)  ·  Caroline Chung (1)  ·  Chad Quarles (1)

Results publications

PMID 19366446, PMID 25479121, PMID 31062234, PMID 32431667, PMID 34081125, PMID 34171339, PMID 35861778, PMID 38883740, PMID 39402027, PMID 39422741, PMID 41206763, PMID 41213248, PMID 42494994, PMID 42556340

NIH funding

P30CA138292 (2), P30CA012197 (1), P30CA013330 (1), P30CA014089 (1), P30CA043703 (1), P30CA068485 (1), P50CA108961 (1), R01CA178200 (1), R03CA255992 (1)